Rangeley Capital, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Rangeley Capital, LLC disclosed 70 US equity positions worth $79.7m in its Q2 2025 13F filing. The largest position was SG7 at 8.4% of the reported book, followed by DK and ARVN. Against the Q1 2025 filing, it opened 23 new positions, added to 10 and reduced 17 among the top 50 holdings.
What did Rangeley Capital, LLC own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | SG7 SAGE THERAPEUTICS INC | 8.4% | $6.7m | 730,000 | 90% | added | |
| 2 | DK DELEK US HLDGS INC NEW | Energy | 8.3% | $6.6m | 313,000 | -8% | reduced |
| 3 | ARVN ARVINAS INC | Healthcare | 6.4% | $5.1m | 694,800 | 28% | added |
| 4 | CLMT CALUMET INC | 6.3% | $5.0m | 319,000 | -39% | reduced | |
| 5 | PROTHENA CORP PLC | 5.4% | $4.3m | 715,367 | – | new | |
| 6 | KROS KEROS THERAPEUTICS INC | Healthcare | 4.8% | $3.8m | 285,400 | -30% | reduced |
| 7 | SGRY SURGERY PARTNERS INC | Healthcare | 4.6% | $3.7m | 166,060 | 83% | added |
| 8 | WOW WIDEOPENWEST INC | 4.1% | $3.2m | 799,000 | 6% | added | |
| 9 | FLL FULL HSE RESORTS INC | Consumer Cyclical | 4.1% | $3.2m | 882,426 | -1% | reduced |
| 10 | 2662247D ITEOS THERAPEUTICS INC | 3.8% | $3.0m | 302,080 | – | new | |
| 11 | SEG SEAPORT ENTMT GROUP INC | 3.7% | $2.9m | 158,000 | -4% | reduced | |
| 12 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 3.4% | $2.7m | 865,000 | -36% | reduced |
| 13 | CORZ CORE SCIENTIFIC INC NEW | 3.1% | $2.5m | 146,200 | – | new | |
| 14 | NLOP NET LEASE OFFICE PROPERTIES | 2.9% | $2.3m | 70,000 | -36% | reduced | |
| 15 | SKAA SKECHERS U S A INC | 2.8% | $2.3m | 36,000 | – | new | |
| 16 | THIRD HARMONIC BIO INC | 2.0% | $1.6m | 290,000 | 7% | added | |
| 17 | CDZI CADIZ INC | 1.8% | $1.4m | 469,000 | -26% | reduced | |
| 18 | STHO STAR HLDGS | 1.7% | $1.3m | 172,000 | 33% | added | |
| 19 | CVR PARTNERS LP | 1.7% | $1.3m | 15,000 | -35% | reduced | |
| 20 | GEL GENESIS ENERGY L P | 1.6% | $1.3m | 74,000 | -61% | reduced | |
| 21 | WBA WALGREENS BOOTS ALLIANCE INC | 1.5% | $1.2m | 102,000 | – | new | |
| 22 | NRP NATURAL RESOURCE PARTNERS L | 1.4% | $1.2m | 12,100 | – | new | |
| 23 | AMPY AMPLIFY ENERGY CORP NEW | 1.1% | $896.0k | 280,000 | -75% | reduced | |
| 24 | BUR BURFORD CAP LTD | Financial Services | 0.9% | $727.3k | 51,000 | -85% | reduced |
| 25 | VERVE THERAPEUTICS INC | 0.9% | $696.3k | 62,000 | – | new | |
| 26 | KURA KURA ONCOLOGY INC | Healthcare | 0.8% | $669.3k | 116,000 | – | new |
| 27 | LNSR LENSAR INC | 0.8% | $658.5k | 50,000 | – | new | |
| 28 | 2655787D BLUEPRINT MEDICINES CORP | 0.8% | $640.9k | 5,000 | – | new | |
| 29 | SEPN SEPTERNA INC | 0.8% | $619.5k | 58,605 | 11% | added | |
| 30 | SWKHL SWK HLDGS CORP | 0.8% | $604.3k | 41,000 | -6% | reduced | |
| 31 | SOC SABLE OFFSHORE CORP | 0.7% | $549.5k | 25,000 | – | new | |
| 32 | HEPS D MARKET ELECTR SVCS & TRADI | 0.7% | $540.0k | 200,000 | 39% | added | |
| 33 | VIGL VIGIL NEUROSCIENCE INC | 0.7% | $539.0k | 67,800 | – | new | |
| 34 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.7% | $521.2k | 75,000 | – | new |
| 35 | RPTX REPARE THERAPEUTICS INC | 0.6% | $493.9k | 355,292 | – | new | |
| 36 | SITC SITE CTRS CORP | 0.6% | $452.4k | 40,001 | 228% | added | |
| 37 | TBPH THERAVANCE BIOPHARMA INC | Healthcare | 0.5% | $372.0k | 33,729 | – | new |
| 38 | ELEVATION ONCOLOGY INC | 0.4% | $332.3k | 905,289 | – | new | |
| 39 | MOUNTAIN LAKE ACQUISITION CO | 0.4% | $307.8k | 30,000 | -62% | reduced | |
| 40 | HILLEVAX INC | 0.4% | $306.0k | 153,790 | – | new | |
| 41 | EPIEUR ESSA PHARMA INC | 0.4% | $289.0k | 170,000 | – | new | |
| 42 | BRSL INTERNATIONAL GAME TECHNOLOG | Consumer Cyclical | 0.3% | $268.8k | 17,000 | 19% | added |
| 43 | KEL KELLANOVA | 0.3% | $238.6k | 3,000 | – | new | |
| 44 | NBIS NEBIUS GROUP N.V. | Communication Services | 0.3% | $215.8k | 3,900 | -61% | reduced |
| 45 | PERCEPTIVE CAP SOLUTIONS COR | 0.3% | $212.4k | 20,000 | – | new | |
| 46 | 75Z SOHO HOUSE & CO INC | 0.3% | $202.9k | 27,600 | -19% | reduced | |
| 47 | AVIR ATEA PHARMACEUTICALS INC | Healthcare | 0.2% | $190.8k | 53,000 | – | new |
| 48 | CRGX CARGO THERAPEUTICS INC | 0.2% | $172.4k | 41,851 | -49% | reduced | |
| 49 | ARES ACQUISITION CORP II | 0.2% | $135.1k | 11,920 | – | new | |
| 50 | GSR III ACQUISITION CORP | 0.1% | $118.7k | 11,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.